Oklahoma City, OK. – October 18, 2019 – Cytovance® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate in the upcoming Recent Advances in Fermentation Technology (#RAFT) Conference to be held October 29 – November 1, 2017 at the Hyatt Coconut Point, Bonita Springs (Ft. Myers), Florida.

RAFT’s theme, sponsored by the Society for Industrial Microbiology and Biotechnology (#SIMB) is “Driving Innovation and Stability from R&D to Commercialization and Beyond.”

Dr. Frank Agbogbo, PhD, Cyotvance’s Director of Microbial Bioprocess  will be co-leading a scientific discussion on “Bench to the manufacturing suite: Scale-up and Tech transfer.”  Commercialization of fermentation processes can be both challenging and rewarding. Some of these challenges include differences in oxygen transfer, mixing, shear, raw materials, measurement systems, heterogeneity, and equipment capability. This session will give scientists and engineers a chance to share their research, experiences, and insights into delivering a process to the marketplace and sustaining that process after commercialization.